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characteristic of infection (Figure). Spatial information is
retained allowing for visualization and quantiﬁcation of
disease within individual lobes. The relative volumes for
each classiﬁcation are determined by normalizing the sum
of all voxels within a particular class to the total lung
volume. Using HRCT, broncho-alveolar lavage (BAL) and
spirometry data, 55 SCT recipients were classiﬁed into one
of 3 groups: A) Infection, no BOS (n¼11); B) BOS, no
infection (n¼34); and C) BOS + Infection (n¼9). BAL were
performed within 1 week of the HRCT, in all 55 patients.
Mean values (SE) for functional small airway disease
(fSAD), parenchymal (infectious) disease (PD), and normal
lung parenchyma were determined for each group
(Figure).
Results: Distinct imaging proﬁles were identiﬁed for pa-
tients with BOS and for patients with an acute infectious
pneumonitis. In particular, the %fSAD was signiﬁcantly
greater in patients with BOS when compared to those with
infection alone, 382% vs 174%, p¼0.05. There was no
difference in the %fSAD for subjects with BOS, whether a
concurrent infection was present or not, 353% (BOS) vs
382% (BOS + Infection), p¼31. Patients with an acute in-
fectious pneumonitis had signiﬁcantly higher levels of PD
than patients with BOS, 304% vs 171.5%. In 7 of the 34
(21%) BOS cases, signiﬁcant increases in fSAD (>30%) were
present when radiographic features characteristic for BOS
(air trapping, bronchiectasis, septal lines) were either ab-
sent or minimal on HRCT. There were no differences in
PRM imaging by the type of infection. PRM provides a
major advance in our ability to diagnose small airway
obstruction that characterizes BOS, even in the presence of
an active pulmonary infection. A prospective trial
comparing PRM with spirometry and standard HRCT as an
early indicator of BOS is planned.CRA -DATA MANAGEMENT313
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Background: The University of Maryland Blood and Marrow
Transplant (BMT) team has ﬁrmly established a culture of
continuous quality improvement to assure the utmost ac-
curacy of CIBMTR data. In early 2012, Minas and Ruehlereported the signiﬁcance of auditing 10 commonly used
data points. In early 2013, Minas and Ruehle set out to
further improve CIBMTR data accuracy by combining their
original set of commonly used data points with 19 addi-
tional ones.
Methods: To explore the internal assessments (IA) audit
activities used by other transplant centers to ensure
CIBMTR data accuracy, the University of Maryland BMT
team developed an anonymous survey consisting of 6
quantitative and 3 qualitative questions. One hundred and
thirty seven NMDP (National Marrow Donor Program) and
CIBMTR (Center for International Blood and Marrow
Transplant Research) afﬁliated transplant centers (TC) were
invited to participate. The survey was administered using
Survey Monkey.
Results: A total of 86 (62.8%) responses were received. Of
these, 57% were from centers that transplanted over 100
patients per year. Most TC (89%) performed some type of IA
for their CIBMTR forms. Centers reported that IA were most
often conducted by a quality assurancemanager (46%). Of the
TC that performed IA, 76% reported using FACT (Foundation
for the Accreditation of Cellular Therapy) and additional data
points as opposed to only FACT data points. Fifty-six percent
of TC that conducted IA reported that audits were performed
on 10%-30% of patient data on a regular basis, while another
19% reported performing IA for 100% of patient data. Internal
assessments were most commonly performed on a quarterly
basis (35%).
Conclusion: Most TC participate in some sort of IA. The
majority of TC perform IA using FACT and additional data
points, which likely improves accuracy of the data. Although
time is a consideration, completing 100% IA assures the most
accurate data. Surveys such as these provide us with
knowledge of how all transplant centers assure quality
CIBMTR data and prepare for external audits, such as CIBMTR
and FACT.
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Organizing data into coherent groups, i.e. data domains, is
key to understanding relations between complex subject
areas such as information collected around one simple
